Financial News
Crispr Therapeutics Ag (NQ: CRSP )
Price and Volume
Detailed QuoteVolume | 1,161,259 |
Open | 47.21 |
Bid (Size) | 46.67 (7) |
Ask (Size) | 46.72 (1) |
Prev. Close | 47.26 |
Today's Range | 45.51 - 47.21 |
52wk Range | 43.42 - 91.10 |
Shares Outstanding | 78,935,098 |
Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read More
Where Will CRISPR Therapeutics Be in 3 Years?
November 15, 2024
3 Unstoppable Growth Stocks I'm Loading $25,000 Each Into by 2029
November 13, 2024
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
November 08, 2024
Smaller Cap Biotechs Are In Season: How Are We Doing?
November 07, 2024
3 Companies Building Tomorrow's Game-Changing Technologies
November 05, 2024
Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers
November 02, 2024
12 High-Growth Stocks That Could Deliver Parabolic Returns
October 28, 2024
The Ultimate Biotech Stock to Buy With $50 Right Now
October 26, 2024
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
October 22, 2024
Why We Buy Stocks
October 21, 2024
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
October 19, 2024
Why I Keep Buying These 14 Incredible Growth Stocks
October 16, 2024
Is CRISPR Therapeutics Stock a Buy?
October 13, 2024
2 Biotech Stocks That Are Screaming Buys This Month
October 12, 2024
This Healthcare Growth Stock Could Be a Steal of a Deal Right Now
October 05, 2024
3 Dirt Cheap Stocks to Buy Right Now
September 21, 2024
Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?
September 19, 2024
1 Biotech Stock Down 62% to Buy and Hold
September 12, 2024
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
September 12, 2024
Looking for Stock Bargains With Room to Run? Try This.
September 11, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.